Showing 161 - 173 results of 173 for search 'active crohn’s disease.', query time: 0.05s Refine Results
  1. 161

    Practice affairs committee by Dan Sadowski

    Published 2004-01-01
    “…The principle mandate of the committee is to address all issues relevant to the practice of gastroenterology, such as participation in the development of clinical practice guidelines and education programs, and the facilitation of clinical research. A major activity in 2003 was participation in the drafting of several new clinical practice guidelines: Infliximab and the management of Crohn's disease;Screening for colorectal cancer; andManagement of gastroesophageal reflux disease.…”
    Get full text
    Article
  2. 162

    Cyanoacrylate Associated Foreign Body Granulomatous Gastritis: A Report of Three Cases by Gunes Guner, Olcay Kurtulan, Taylan Kav, Cenk Sokmensuer, Gokhan Gedikoglu, Aytekin Akyol

    Published 2017-01-01
    “…Granulomas are rarely seen in gastric biopsies mostly as an involvement of granulomatous diseases like sarcoidosis, Crohn’s disease, infections, neoplasms, and vasculitis. …”
    Get full text
    Article
  3. 163

    Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD by Katarzyna Neubauer, Malgorzata Matusiewicz, Iwona Bednarz-Misa, Sabina Gorska, Andrzej Gamian, Malgorzata Krzystek-Korpacka

    Published 2018-01-01
    “…We assessed the concentrations of eosinophil-associated cytokines and growth factors in the group of 277 individuals (101 patients with Crohn’s disease (CD), 77 with ulcerative colitis (UC), 16 with irritable bowel syndrome (IBS), and 83 healthy controls) and referred to IBD activity and the levels of hsCRP. …”
    Get full text
    Article
  4. 164

    Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial by Philip J Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Jürgen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Evie Maria Delicha, Shephard Mpofu, Luminita Pricop

    Published 2018-08-01
    “…Exposure-adjusted incidence rates for selected adverse events per 100 patient-years (secukinumab 150/75 mg) were serious infections (1.7/1.6), Candida infections (1.4/0.7), Crohn’s disease (0/0.3), ulcerative colitis (0/0.3) and major adverse cardiac events (0.3/0.8).Conclusion Subcutaneous secukinumab provided sustained improvements in the signs and symptoms, quality of life and physical function of patients with active PsA with low rate of radiographic disease progression through 3 years. …”
    Get full text
    Article
  5. 165
  6. 166

    IBD 2009: Emerging Research Frontiers on the Path to a Cure by A Hillary Steinhart, G Tolomiczenko

    Published 2010-01-01
    “…Following the scientific presentations, discussions endorsed current activities of the CCFC and supported the creation of a new pediatric inflammatory bowel disease initiative.…”
    Get full text
    Article
  7. 167

    In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors by Halim Sobia Ahsan, Zaheer-Ul-Haq, Khan Ajmal, Al-Rawahi Ahmed, Al-Harrasi Ahmed

    Published 2021-03-01
    “…Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn’s disease. …”
    Get full text
    Article
  8. 168

    Gut Mesenchymal Stromal Cells in Immunity by Valeria Messina, Carla Buccione, Giulia Marotta, Giovanna Ziccheddu, Michele Signore, Gianfranco Mattia, Rossella Puglisi, Benedetto Sacchetti, Livia Biancone, Mauro Valtieri

    Published 2017-01-01
    “…The reversal of myofibroblasts/MSCs from an immune-modulator to an activator phenotype in Crohn’s disease results in the formation of a fibrotic tube subverting the intestinal structure. …”
    Get full text
    Article
  9. 169

    Rapamycin Alleviates 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis through Autophagy Induction and NF-κB Pathway Inhibition in Mice by Zhen Ni, Hao Li, Dong Mu, Juanni Hou, Xiaoyan Liu, Shanhong Tang, Shumei Zheng

    Published 2022-01-01
    “…Recent genetic studies indicated that variants of autophagy genes were associated with the predisposition of Crohn’s disease (CD). The autophagy deficiency may affect the innate and adaptive immunity, which is related to persistent and excessive inflammation of the bowel. …”
    Get full text
    Article
  10. 170

    Interleukin-23 and Th17 Cells in the Control of Gut Inflammation by Ivan Monteleone, Francesco Pallone, Giovanni Monteleone

    Published 2009-01-01
    “…Crohn's Disease and Ulcerative Colitis, the major forms of inflammatory bowel diseases (IBDs) in humans, have been traditionally associated with exaggerated and poorly controlled T helper (Th) type 1 or Th2 cell response, respectively. …”
    Get full text
    Article
  11. 171

    Lipopolysaccharide and silica-stimulated mononuclear cell prostaglandin production in ulcerative colitis by Neville A. Punchard, John Cason, Jonathan Mullins, Chaman Chander, Richard P. H. Thompson

    Published 2000-01-01
    “…That PBMNC PGE2 production is not increased in UC, as it is in Crohn’s disease, suggests that there are differences in PBMNC behaviour between these two diseases.…”
    Get full text
    Article
  12. 172

    The Chemical Composition of Endotoxin Isolated from Intestinal Strain of Desulfovibrio desulfuricans by Jolanta Lodowska, Daniel Wolny, Marzena Jaworska-Kik, Sławomir Kurkiewicz, Zofia Dzierżewicz, Ludmiła Węglarz

    Published 2012-01-01
    “…There are suggestions that they take part in the pathogenesis of periodontitis and some gastrointestinal inflammatory disorders, such as ulcerative colitis or Crohn’s disease. Endotoxin is one of Gram-negative bacteria cellular components that influence these microorganisms pathogenicity. …”
    Get full text
    Article
  13. 173

    High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD by Alberto J. León, Emma Gómez, Jose A. Garrote, David Bernardo, Asterio Barrera, Jose L. Marcos, Luis Fernández-Salazar, Benito Velayos, Alfredo Blanco-Quirós, Eduardo Arranz

    Published 2009-01-01
    “…Biopsy specimens from patients with ulcerative colitis (UC) and Crohn's disease (CD), from both affected and unaffected areas, and also from a group of colonic biopsies from healthy controls, were included in our study. …”
    Get full text
    Article